Christopher Barnett, MD: Acceleron: Clinical Trial Investigator (Ongoing); United Therapeutics: Clinical Trial Investigator (Terminated)
Cardiogenic shock develops in some patients with sepsis without underlying cardiac disease. The risk factors, implications and treatment of this syndrome are discussed.
Presentations included: Pathophysiology of Septic Cardiomyopathy: Back to Basics - Margaret Parker, MD, MCCM Diagnosis and imaging of Septic Cardiomyopathy - Siddharth Dugar, MD, FCCM Implications and Treatment of Cardiogenic Shock in Sepsis - Christopher Barnett, MD
